ArticleJournal of cancer research and clinical oncology2023

Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker.

Zhujiang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.